A carregar...
First-line treatment options in metastatic renal cell cancer
The introduction of targeted therapy a decade ago revolutionized the treatment of metastatic renal cell carcinoma (mRCC). The current standard of care focuses on the inhibition of angiogenesis through the targeting of the vascular endothelial growth factor receptor (VEGFR) and the mammalian target o...
Na minha lista:
| Publicado no: | Can Urol Assoc J |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Canadian Medical Association
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5215299/ https://ncbi.nlm.nih.gov/pubmed/28096934 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.4307 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|